FAQs: Applying AI to ABA Clinical Practice

1. What are the CASP Practice Parameters for Artificial Intelligence?

The CASP Practice Parameters for Artificial Intelligence are governance guidelines developed for AI use in ABA that are specific to behavior-analytic practice. Key principles include that AI should enhance rather than replace clinical skill, outputs should be interpretable by clinicians, practitioners retain responsibility for AI-assisted decisions, and implementation must attend to equity implications for the populations served. These parameters provide a framework for evaluating AI tools before adoption rather than using them uncritically.

2. What are the most promising clinical applications of AI in ABA?

The most promising near-term applications include AI-assisted documentation that reduces the administrative burden on practitioners, automated behavior coding from video that can improve consistency across long observation windows, and data analysis tools that flag anomalies or patterns in behavioral data that might be missed in manual review. These applications have the potential to free practitioner time for direct clinical work and to improve the consistency of behavioral measurement.

3. What validation evidence should I require before using an AI tool in clinical practice?

You should require evidence of sensitivity, specificity, and error rates on populations comparable to your caseload. Validation should cover the full range of behavioral forms, environmental conditions, and client characteristics relevant to your setting. Kerry et al.

(2026) demonstrate the level of psychometric rigor that clinical measurement tools require. AI tools should meet the same standard before being trusted for clinical decisions.

4. Who is responsible when an AI tool contributes to a clinical error?

The behavior analyst remains fully responsible for all clinical decisions, regardless of whether an AI tool assisted in making them. The BACB Ethics Code (2022) does not recognize algorithmic assistance as a factor that reduces practitioner accountability. Practitioners using AI tools must be able to evaluate the tool's recommendations critically—which means having sufficient expertise in the relevant clinical domain and sufficient understanding of how the tool generates its outputs.

5. What are the equity risks of AI deployment in ABA practice?

AI systems trained on datasets that underrepresent certain racial, linguistic, or diagnostic groups may perform systematically worse for those groups. This can produce less accurate behavior codes, more documentation errors, and less reliable clinical decision support for the clients most likely to already be underserved by the healthcare system. Alnahdi & Morin (2026) illustrate how measurement tools carry cultural assumptions that must be examined before cross-cultural deployment—the same scrutiny applies to AI systems.

6. What data privacy obligations apply to AI tools that process client behavioral data?

HIPAA provides minimum requirements for protected health information, but practitioners should evaluate whether AI tool vendors' data practices meet professional ethics standards above that floor. Informed consent processes must inform families about what data is being collected, how it is being used, who has access to it, and what safeguards are in place. Practitioners should not adopt AI tools that require sharing client behavioral data without conducting this consent and evaluation process explicitly.

7. What does 'AI should enhance clinical skill rather than replace it' mean in practice?

This principle means that AI integration should be evaluated by whether it results in practitioners with better clinical skills, not practitioners who have delegated their clinical judgment to an algorithm. An AI tool that automates documentation so practitioners have more time for assessment and supervision enhances clinical skill. An AI tool that generates treatment recommendations that practitioners implement without critical evaluation may replace clinical judgment rather than enhance it.

8. How do functional assessment principles apply to evaluating AI tools?

Functional assessment asks what maintains a behavior and whether our measurement procedures are capturing that function accurately. Applied to AI tools, this means asking whether the tool's summarization or recommendation logic preserves the functional context of the behavioral data it processes. Kaur et al.

(2026) demonstrate how procedural tools can mask behavioral function. AI tools that summarize behavioral data may introduce similar distortions if their underlying logic does not account for behavioral function.

9. What assessment validation research is relevant to evaluating AI clinical tools?

The validation research most relevant to AI tools is that which examines how clinical measurement instruments perform across diverse populations, including populations with intellectual disabilities, communication difficulties, and minority language backgrounds. Hoogstad et al. (2026) on PTSD assessment for adults with severe intellectual disabilities illustrates the harm risk when unvalidated tools are applied to vulnerable populations—a direct analogy for AI tools deployed in ABA without population-specific validation evidence.

10. What organizational policies should govern AI tool adoption in ABA organizations?

Organizations should establish policies that specify: minimum validation evidence requirements before tool adoption, mandatory practitioner training before clinical use, data privacy standards that exceed HIPAA minimums for sensitive behavioral health data, equity monitoring procedures to detect performance disparities across client groups, and a review process for updating policies as the AI evidence base develops. Policies should be more conservative than vendor documentation suggests when validation evidence is limited.